The Lancet. Psychiatry, 2215-0366

Journal

Related Publications
  1. Discontinuation of antipsychotic medication-time to rethink trial design

    Speyer, H., Begemann, M., Albert, N., Weller, A., Nordentoft, M., Veling, W., Sommer, I. E., Allott, K. & Killackey, E., Oct-2020, In : The Lancet. Psychiatry. 7, 10, p. 841-842 2 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Effectiveness of digital psychological interventions for mental health problems in low-income and middle-income countries: a systematic review and meta-analysis

    Fu, Z., Burger, H., Arjadi, R. & Bockting, C. L. H., 28-Aug-2020, In : The Lancet. Psychiatry. 14 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults

    Dehue, T., Bijl, D., de Winter, M., Scheepers, F., Vanheule, S., van Os, J., Verhaeghe, P. & Verhoeff, B., 1-Jun-2017, In : The Lancet Psychiatry. 4, 6, p. 438-439 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  4. High-potency cannabis and incident psychosis: correcting the causal assumption

    Sommer, I. E. & van den Brink, W., Jun-2019, In : The Lancet. Psychiatry. 6, 6, p. 464-465 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

  5. Antipsychotic treatments: who is really failing here? Reply

    Kahn, R. S. & Sommer, I. E., Oct-2018, In : The Lancet. Psychiatry. 5, 10, p. 785-786 2 p.

    Research output: Contribution to journalLetterAcademicpeer-review

View all (17) »

ID: 19941134